UBS Group’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History
Bought
Maintained
Sold
Other funds holding BOUT
CWM
CMMS
MMCM
ADL
HCM
IA
DFA
UBS Group's BOUT Position: Q2 2026 in Review
UBS Group sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2026, closing a stake of 330 shares — an estimated $13K sold.
UBS Group first reported a position in BOUT in Q1 2019 and held it in 26 quarters. The position peaked at $66K in Q1 2021. 12 funds tracked by Wall St. Rank hold BOUT as of Q2 2026.
- UBS Group reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 330 CapForce IBD Breakout Opportunities ETF shares in Q2 2026, an estimated $13K.
- UBS Group first reported a position in CapForce IBD Breakout Opportunities ETF in Q1 2019 and held it in 26 quarters.
- UBS Group's CapForce IBD Breakout Opportunities ETF position peaked at $66K in Q1 2021.
- 12 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.